Key Insights

Highlights

Treatment Research

1 treatments under study, led by Oncological Followup

Research Leaders

13 sponsors active, led by Catharina Ziekenhuis Eindhoven

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Recruiting1
Not Yet Recruiting1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07883551Not Yet Recruiting

AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery

NCT05500391Phase 2Recruiting

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

NCT05791838UnknownPrimary

Experience in Borderline Ovarian Tumors

Showing all 3 trials

Research Network

Common Treatments

  • Oncological Followup1

Active Sponsors

  • Catharina Ziekenhuis Eindhoven1
  • Groupement Interrégional de Recherche Clinique et d'Innovation1
  • Amphia Hospital1
  • Maastricht University1
  • Antoni van Leeuwenhoek Hospital1

Top Investigators

Related Conditions

  • Ovarian Germ Cell Tumor1
  • Serous Tumor Of Ovary1
  • Ovarian Tumor1
  • Mucinous Adenocarcinoma Of Ovary1
  • Sex Cordstromal Tumor1

Activity Timeline